Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study

Sandro Giannini(University of Padua), Francesco Bertoldo(University of Verona)

Nutrients

January 14, 2021

10.3390/nu13010219

Cited by 83

Related Papers

Mutations in the Insulin-Like Factor 3 Receptor Are Associated With Osteoporosis

|Journal of Bone and Mineral Research|2008|148

Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)

|Nutrients|2022|102

The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation

|Oncotarget|2017|74

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)

|Endocrine|2017|68

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives

|Tumori Journal|2025|1